Evidence map›Paper›PMID 42313350›Full record

ArticleArchives of pharmacal research2026

M2 microglial exosomal miR-1949 ameliorates sepsis-associated encephalopathy through DKK1/Wnt/β-catenin-mediated microglial repolarization.

Yue Cao, Zhaoyang Li, Xiangqi Liu, Hefeng Geng, Haotian Zhang, Yeshu Liu, Tianlin Wang, Jingyu Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of pharmacal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yue CaoDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Zhaoyang LiDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Xiangqi LiuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Hefeng GengDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Haotian ZhangDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Yeshu LiuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Tianlin WangDepartment of Pharmacy, Medical Supplies Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China. wangtl_301@126.com.ORCID http://orcid.org/0000-0002-6589-7483
Jingyu YangDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China. yangjingyu@syphu.edu.cn.ORCID http://orcid.org/0000-0002-2791-5281

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis-associated encephalopathy (SAE), the most common neurological complication of sepsis with high mortality, lacks effective treatments. Although microglia play a significant role in SAE pathogenesis, the mechanisms of M2 microglial exosomes (M2-EXOs) and their microRNAs (miRNAs) remain unclear. The present study demonstrated that both M2 microglial conditioned media (M2-CM) and M2-EXO promote the phenotypic transformation of M1 microglia toward the M2 phenotype. In M2-EXO, among the differentially expressed miRNAs, miR-1949 exhibited the most significant difference. The dual-luciferase assay showed that miR-1949 could bind to the 3'UTR of Dickkopf-related protein 1 (DKK1). Further experiments confirmed that M2-EXO-miR-1949 mimic mediated microglial phenotypic transformation by inhibiting DKK1 and activating the Wnt/β-catenin pathway. Notably, a single injection of M2-EXO (10 μg/mouse, i.c.v.) or M2-EXO-miR-1949 mimic (0.1 nmol/mouse, i.c.v.) significantly reduced the mouse sepsis score (MSS), decreased cortical neural cell damage in SAE mice induced by lipopolysaccharide (LPS), inhibiting abnormal microglial activation and alleviating neuroinflammation. Meanwhile, M2-EXO-miR-1949 mimic markedly inhibited DKK1 and activated the Wnt/β-catenin pathway in vivo. What's more, the effects of M2-EXO-miR-1949 mimic were reversed by the Wnt/β-catenin pathway inhibitor XAV939. In contrast, the effect of M2-EXO-miR-1949 inhibitor (0.1 nmol/mouse, i.c.v.) was opposite to that of M2-EXO-miR-1949 mimic. Furthermore, co-transfection of the M2-EXO-miR-1949 mimic and inhibitor mutually neutralized their opposing effects, resulting in no significant changes in the expression of inflammatory and pathway-related markers, thereby confirming the functional specificity of exosomal miR-1949. In summary, the present study indicates that M2-EXO, especially its contained miR-1949, ameliorates LPS-induced SAE in mice through inhibiting DKK1 to activate the Wnt/β-catenin pathway, thereby leading to microglial phenotypic transformation and neuroinflammation inhibition. This study reveals a novel mechanism by which M2-EXO and miRNA ameliorate SAE, providing a theoretical basis for further studies.

Indexed as

beta CateninExosomesIntercellular Signaling Peptides and ProteinsMicrogliaMicroRNAsSepsis-Associated EncephalopathyWnt Signaling PathwayAnimalsCells, CulturedLipopolysaccharidesMaleMiceMice, Inbred C57BLbeta CateninDkk1 protein, mouseIntercellular Signaling Peptides and ProteinsLipopolysaccharidesMicroRNAsExosomesMicrogliaMiR-1949NeuroinflammationPhenotypic transformationSepsis-associated encephalopathy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.